Literature DB >> 17101031

24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression.

Masachika Fujiyoshi1, Sumio Ohtsuki, Satoko Hori, Masanori Tachikawa, Tetsuya Terasaki.   

Abstract

The release of cholesterol from choroid plexus epithelial cells (CPE) plays an important role in cholesterol homeostasis in the CSF. The purpose of this study was to clarify the molecules involved in cholesterol release in CPE and the regulation mechanisms of the cholesterol release by the liver X receptor (LXR) using a conditionally immortalized CPE line (TR-CSFB3). The mRNA expression of LXRalpha, LXRbeta and their target genes, ATP-binding cassette transporter (ABC)A1, ABCG1, ABCG4 and ABCG5, were detected in rat choroid plexus. ABCA1 and ABCG1 protein were detected in the plasma membrane of TR-CSFB3 cells. Following treatment with 24S-hydroxycholesterol, an endogenous LXR ligand, the expression of ABCA1 and ABCG1 were induced in TR-CSFB3 cells. Moreover, apolipoprotein (apo)AI- and high-density lipoprotein (HDL)-mediated cholesterol release to the apical side of TR-CSFB3 cells was facilitated by this treatment, whereas that to the basal side was not affected. Following 24S-hydroxycholesterol treatment, apoE3-dependent cholesterol release from TR-CSFB3 cells was enhanced more than the apoE4-dependent release. These results suggest that LXR activation facilitates cholesterol release into the CSF from CPE through the functional induction of ABCA1 and ABCG1. The difference between apoE3 and apoE4 suggests that the cholesterol release from CPE is related to the development of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101031     DOI: 10.1111/j.1471-4159.2006.04240.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 2.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

3.  Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function.

Authors:  Joanna M Karasinska; Franz Rinninger; Dieter Lütjohann; Piers Ruddle; Sonia Franciosi; Janine K Kruit; Roshni R Singaraja; Veronica Hirsch-Reinshagen; Jianjia Fan; Liam R Brunham; Nagat Bissada; Rajasekhar Ramakrishnan; Cheryl L Wellington; John S Parks; Michael R Hayden
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

4.  24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.

Authors:  Casandra M Cartagena; Mark P Burns; G William Rebeck
Journal:  Brain Res       Date:  2010-01-04       Impact factor: 3.252

5.  Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.

Authors:  Sokreine Suon; Jie Zhao; Stephanie A Villarreal; Nikesh Anumula; Mali Liu; Linda M Carangia; John J Renger; Celina V Zerbinatti
Journal:  Mol Neurodegener       Date:  2010-10-29       Impact factor: 14.195

6.  Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma.

Authors:  Risheng Yang; Yuanlin Zhao; Yu Gu; Ying Yang; Xing Gao; Yuan Yuan; Liming Xiao; Jin Zhang; Chao Sun; Han Yang; Junhui Qin; Jing Li; Feng Zhang; Lijun Zhang; Jing Ye
Journal:  Oncogene       Date:  2020-08-27       Impact factor: 9.867

Review 7.  Impact of apolipoprotein E on Alzheimer's disease.

Authors:  Paul S Hauser; Robert O Ryan
Journal:  Curr Alzheimer Res       Date:  2013-10       Impact factor: 3.498

8.  Choroid plexus implants rescue Alzheimer's disease-like pathologies by modulating amyloid-β degradation.

Authors:  Marta Bolos; Desireé Antequera; Jesús Aldudo; Henrike Kristen; María Jesús Bullido; Eva Carro
Journal:  Cell Mol Life Sci       Date:  2013-12-17       Impact factor: 9.261

9.  24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation.

Authors:  Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

10.  Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain.

Authors:  Koichi Matsumoto; Yoichi Chiba; Ryuji Fujihara; Hiroyuki Kubo; Haruhiko Sakamoto; Masaki Ueno
Journal:  Histochem Cell Biol       Date:  2015-10-08       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.